Cas9 protein delivery with EMX sgRNA to cochlea of mouse in vivo
To evaluate the DNA cleavage efficiency of Cas9 delivered as protein complexed with either EMX sgRNA in liposomes to the mouse cochlea in vivo, we measured the modification of on-target genomic target sites EMX. The target sites were amplified from genomic DNA isolated 10 days post treatment.